Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 246

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Magnesium sulphate versus phenytoin for eclampsia

Open access
Duley, Lelia, Henderson-Smart, David J, Chou, Doris·2010·Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Eclampsia, the occurrence of a seizure in association with pre-eclampsia, remains a rare but serious complication of pregnancy. A number of different anticonvulsants have been used to control eclamptic fits and to prevent further seizures. OBJECTIVES: The objective of this review was to assess the effects of magnesium sulphate compared with phenytoin when used for the care of women with eclampsia. Magnesium sulphate is compared with diazepam and with lytic cocktail in other Cochrane reviews. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2010). SELECTION CRITERIA: Randomised trials comparing magnesium sulphate (intravenous or intramuscular administration) with phenytoin for women with a clinical diagnosis of eclampsia. DATA COLLECTION AND ANALYSIS: Two review authors assessed trial quality and extracted data. MAIN RESULTS: We have included data from seven trials, involving 972 women. One large trial (775 women) was of good quality. Magnesium sulphate was associated with a substantial reduction in the recurrence of seizures, when compared to phenytoin (six trials, 972 women; risk ratio (RR) 0.34, 95% confidence interval (CI) 0.24 to 0.49). The trend in maternal mortality favours magnesium sulphate, but the difference does not reach statistical significance (three trials, 847 women; RR 0.50, 95% CI 0.24 to 1.05). There were reductions in the risk of pneumonia (one trial, RR 0.44, 95% CI 0.24 to 0.79), ventilation (one trial, RR 0.68, 95% CI 0.50 to 0.91) and admission to an intensive care unit (one trial, RR 0.67, 95% CI 0.50 to 0.89) associated with the use of magnesium sulphate rather than phenytoin.For the baby, magnesium sulphate was associated with fewer admissions to a special care baby unit (SCBU) (one trial, 518 babies; RR 0.73, 95% CI 0.58 to 0.91) and fewer babies who died or were in SCBU for more than seven days (one trial, 643 babies; RR 0.77, 95% CI 0.63 to 0.95) than phenytoin. There was no clear difference in perinatal deaths (two trials, 665 babies; (RR 0.85, 95% CI 0.67 to 1.09). AUTHORS' CONCLUSIONS: Magnesium sulphate, rather than phenytoin, for women with eclampsia reduces the risk ratio of recurrence of seizures, probably reduces the risk of maternal death, and improves outcome for the baby. Magnesium sulphate is the drug of choice for women with eclampsia. The use of phenytoin should be abandoned.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd000128.pub2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 87

  1. Valadares Neto, 2000, Treatment of eclampsia: comparative study on the use of magnesium sulfate and phenytoin, Revista Brasileira de Ginecologia e Obstetricia, 22, 543, 10.1590/S0100-72032000000900002 · doi:10.1590/s0100-72032000000900002
  2. Duley, 1995, Magnesium and eclampsia, Lancet, 346, 1365, 10.1016/S0140-6736(95)92377-2 · DOI
  3. Duley, 1998, Magnesium sulphate in eclampsia, Lancet, 352, 67, 10.1016/S0140-6736(05)79550-7 · DOI
  4. Duley, 1996, Magnesium sulphate regimens for women with eclampsia: messages from the Collaborative Eclampsia Trial, British Journal of Obstetrics and Gynaecology, 103, 103, 10.1111/j.1471-0528.1996.tb09657.x · DOI
  5. Duley, 1996, Magnesium sulphate should be used for eclamptic fits, BMJ, 312, 639, 10.1136/bmj.312.7031.639 · doi:10.1136/bmj.312.7031.639
  6. Duley L Magnesium sulphate, diazepam or phenytoin for women with eclampsia: results of the Collaborative Eclampsia Trial Proceedings of the 27th British Congress of Obstetrics and Gynaecology; 1995 July 4-7; Dublin, 1995:32
  7. The Eclampsia Trial Collaborative Group, 1995, Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial, Lancet, 345, 1455, 10.1016/S0140-6736(95)91034-4 · DOI · Paper page
  8. Sawhney, 1999, Efficacy of magnesium sulphate and phenytoin in the management of eclampsia, Journal of Obstetrics and Gynaecology Research, 25, 333, 10.1111/j.1447-0756.1999.tb01172.x · doi:10.1111/j.1447-0756.1999.tb01172.x
  9. Dommisse, 1990, Phenytoin sodium and magnesium sulphate in the management of eclampsia, British Journal of Obstetrics and Gynaecology, 97, 104, 10.1111/j.1471-0528.1990.tb01734.x · doi:10.1111/j.1471-0528.1990.tb01734.x
  10. Naidu, 1996, Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound, British Journal of Obstetrics and Gynaecology, 103, 111, 10.1111/j.1471-0528.1996.tb09660.x · doi:10.1111/j.1471-0528.1996.tb09660.x
  11. Payne AJ Naidu S Moodley J Hoffmann M Gouws E Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial doppler ultrasound Proceedings of the 27th British Congress of Obstetrics and Gynaecology; 1995 July 4-7; Dublin, Ireland 1995 302
  12. Friedman, 1993, Phenytoin versus magnesium sulphate in pre-eclampsia: a pilot study, American Journal of Perinatology, 10, 233, 10.1055/s-2007-994727 · doi:10.1055/s-2007-994727
  13. Friedman SA Kee-Hak L Cathy A Baker BS Repke JT A comparison of phenytoin infusion vs magnesium sulfate infusion in preeclampsia Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23-27; Houston, Texas, USA 1990 16
  14. Friedman, 1995, Phenytoin versus magnesium sulfate in patients with eclampsia: preliminary results from a randomized trial, American Journal of Obstetrics and Gynecology, 172, 384, 10.1016/0002-9378(95)91142-1 · doi:10.1016/0002-9378(95)91142-1
  15. Chatterjee, 1997, Comparative study of different anticonvulsants in eclampsia, Journal of Obstetrics and Gynaecology Research, 23, 289, 10.1111/j.1447-0756.1997.tb00847.x · doi:10.1111/j.1447-0756.1997.tb00847.x
  16. Chatterjee, 1994, Comparative study of anticonvulsants in eclampsia, International Journal of Gynecology & Obstetrics, 46, 121
  17. Hangarga, 2001, A comparative study of phenytoin sodium with magnesium sulphate and Menon's regime in the treatment of eclampsia, Journal of Obstetrics and Gynecology of India, 51, 68
  18. Appleton, 1991, Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension, American Journal of Obstetrics and Gynecology, 65, 907, 10.1016/0002-9378(91)90437-V · doi:10.1016/0002-9378(91)90437-v
  19. Aaserud, 2005, Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia, BMC Health Services Research, 5, 68, 10.1186/1472-6963-5-68 · DOI
  20. Abalos, 2007, Antihypertensive drug therapy for mild to moderate hypertension during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002252.pub2 · DOI · Paper page
  21. Ananth, 1995, Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991, Acta Obstetricia et Gynecologica Scandinavica, 74, 788, 10.3109/00016349509021198 · DOI
  22. Andersgaard, 2006, Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable cases, Acta Obstetricia et Gynecologica Scandinavica, 85, 929, 10.1080/00016340600607149 · doi:10.1080/00016340600607149
  23. Belfort, 1992, Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study, American Journal of Obstetrics and Gynecology, 167, 661, 10.1016/S0002-9378(11)91567-1 · DOI · Paper page
  24. Churchill, 2002, Interventionist versus expectant care for severe pre-eclampsia before term, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003106 · DOI
  25. Coyaji, 1990, Single high dose of intravenous phenytoin sodium for the treatment of eclampsia, Acta Obstetricia et Gynecologica Scandinavica, 69, 115, 10.3109/00016349009006154 · DOI
  26. Dinsdale, 1988, Does magnesium sulfate treat eclamptic seizures? Yes, Archives of Neurology, 45, 1360, 10.1001/archneur.1988.00520360078016 · doi:10.1001/archneur.1988.00520360078016
  27. Douglas, 1994, Eclampsia in the United Kingdom, BMJ, 309, 1395, 10.1136/bmj.309.6966.1395 · DOI · Paper page
  28. Duley, 1992, Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean, British Journal of Obstetrics and Gynaecology, 99, 547, 10.1111/j.1471-0528.1992.tb13818.x · DOI · Paper page
  29. Duley, 1996, The Collaborative Eclampsia Trial: which anticonvulsant for women with eclampsia [thesis]
  30. Duley, 1999, Plasma volume expansion for treatment of women with pre-eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001805 · DOI
  31. Duley, 2000, Magnesium sulphate versus lytic cocktail for eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002960 · DOI
  32. Duley, 2002, Drugs for treatment of very high blood pressure during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002960 · DOI
  33. Duley, 2003, Magnesium sulphate versus diazepam for eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000127 · DOI
  34. Duley, 2003, Magnesium sulphate and other anticonvulsants for women with pre-eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000025 · DOI · Paper page
  35. Duley, 2005, Altered dietary salt for preventing pre-eclampsia, and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005548 · DOI
  36. Duley, 2007, Antiplatelet agents for preventing pre-eclampsia and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004659.pub2 · DOI · Paper page
  37. Duley, 2008, Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007388 · doi:10.1002/14651858.cd007388
  38. Duley, 2009, Interventions for treating pre-eclampsia and its consequences: generic protocol, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007756 · DOI
  39. Eastman, 1945, The management of pre-eclampsia, Canadian Medical Association Journal, 52, 562
  40. Euser, 2009, Magnesium sulfate for the treatment of eclampsia: a brief review, Stroke, 40, 1169, 10.1161/STROKEAHA.108.527788 · DOI · Paper page
  41. Frias, 2003, Post Magpie: how should we be managing severe preeclampsia?, Current Opinion in Obstetrics and Gynecology, 15, 489, 10.1097/00001703-200312000-00006 · DOI
  42. Friedman, 1993, Phenytoin versus magnesium sulfate in preeclampsia: a pilot study, American Journal of Perinatology, 10, 233, 10.1055/s-2007-994727 · doi:10.1055/s-2007-994727
  43. Goldman RS Finkbeiner SM Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure New England Journal of Medicine 1988 1224 5 · doi:10.1056/nejm198811033191813
  44. Gülmezoglu, 1998, Use of anticonvulsants for eclampsia and pre-eclampsia: a survey of obstetricians in the United Kingdom and Republic of Ireland, BMJ, 316, 975, 10.1136/bmj.316.7136.975 · doi:10.1136/bmj.316.7136.975
  45. Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org · DOI · Paper page
  46. Hofmeyr, 2007, Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary, BJOG : an international journal of obstetrics and gynaecology, 114, 933, 10.1111/j.1471-0528.2007.01389.x · DOI · Paper page
  47. Igberase, 2006, Eclampsia: ten years of experience in a rural tertiary hospital in the Niger delta, Nigeria, Journal of Obstetrics and Gynaecology, 26, 414, 10.1080/01443610600720113 · DOI
  48. Katz, 2000, Preeclampsia into eclampsia: toward a new paradigm, American Journal of Obstetrics and Gynecology, 182, 1389, 10.1067/mob.2000.106178 · doi:10.1067/mob.2000.106178
  49. Knight, 2007, Eclampsia in the United Kingdom 2005, BJOG: an international journal of obstetrics and gynaecology, 114, 1072, 10.1111/j.1471-0528.2007.01423.x · DOI · Paper page
  50. Kullberg, 2002, Eclampsia in Sweden, Hypertension in Pregnancy, 21, 13, 10.1081/PRG-120002906 · DOI
  51. Langer, 2008, Reducing eclampsia-related deaths--a call to action, Lancet, 371, 705, 10.1016/S0140-6736(08)60321-9 · DOI
  52. Lewis, 2007, The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer - 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom
  53. Lumbiganon, 2007, Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be, Bulletin of the World Health Organization, 85, 763, 10.2471/BLT.06.037911 · DOI
  54. Altman, 2002, Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial, Lancet, 359, 1877, 10.1016/S0140-6736(02)08778-0 · DOI · Paper page
  55. Mahomed, 2007, Zinc supplementation for improving pregnancy and infant outcome, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000230.pub3 · DOI
  56. Makrides, 2001, Magnesium supplementation in pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000937 · DOI
  57. Makrides, 2006, Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003402.pub2 · DOI · Paper page
  58. McNamara, 2006, Pharmacotherapy of the epilepsies
  59. Meads, 2008, Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling, Health Technology Assessment, 12, iii-iv, 1-270, 10.3310/hta12060 · DOI · Paper page
  60. Meher, 2005, Interventions for preventing pre-eclampsia and its consequences: generic protocol, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005301 · DOI
  61. Meher, 2006, Exercise or other physical activity for preventing pre-eclampsia and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005942 · DOI
  62. Meher, 2007, Nitric oxide for preventing pre-eclampsia and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006490 · DOI
  63. Milne, 2005, The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community, BMJ, 330, 576, 10.1136/bmj.330.7491.576 · DOI · Paper page
  64. Chang, 2003, Pregnancy-related mortality surveillance--United States, 1991-1999, MMWR. Surveillance Summaries, 52, 1
  65. Naidu, 1992, The efficacy of phenytoin in relation to serum levels in severe pre-eclampsia and eclampsia, British Journal of Obstetrics and Gynaecology, 99, 881, 10.1111/j.1471-0528.1992.tb14434.x · doi:10.1111/j.1471-0528.1992.tb14434.x
  66. Neilson, 1995, Magnesium sulphate: the drug of choice in eclampsia, BMJ (Clinical research ed.), 311, 702
  67. Anonymous, 2000, Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy, American Journal of Obstetrics and Gynecology, 183, S1, 10.1067/mob.2000.107928 · DOI · Paper page
  68. National Institute for Health and Clinical Excellence, 2008, Antenatal care
  69. Onuh, 2004, Maternal and fetal outcome in eclamptic patients in Benin City, Nigeria, Journal of Obstetrics and Gynaecology, 24, 765, 10.1080/01443610400009451 · DOI
  70. Pritchard, 1955, The use of the magnesium ion in the management of eclamptogenic toxemias, Surgery, Gynecology and Obstetrics, 100, 131
  71. Tuffnell, 2006, The management of severe pre-eclampsia/eclampsia. Greentop Guidelines (10A)
  72. Redman, 1984, Hypertension in pregnancy, 141
  73. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008
  74. Roberts, 2002, Preventing and treating eclamptic seizures, BMJ (Clinical research ed.), 325, 609
  75. Roberts, 2005, Hypertensive disorders in pregnancy: a population-based study, Medical Journal of Australia, 182, 332, 10.5694/j.1326-5377.2005.tb06730.x · DOI · Paper page
  76. Robson, 1996, Magnesium sulphate: the time of reckoning, British Journal of Obstetrics and Gynaecology, 103, 99, 10.1111/j.1471-0528.1996.tb09656.x · doi:10.1111/j.1471-0528.1996.tb09656.x
  77. Rumbold, 2008, Antioxidants for preventing pre-eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004227.pub3 · DOI · Paper page
  78. Sadeh, 1989, Action of magnesium sulfate in the treatment of preeclampsia-eclampsia, Stroke, 20, 1273, 10.1161/01.STR.20.9.1273 · doi:10.1161/01.str.20.9.1273
  79. Sevene, 2005, System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe, BMJ, 331, 765, 10.1136/bmj.331.7519.765 · DOI
  80. Sheth, 2002, Magnesium for preventing and treating eclampsia: time for international action, Lancet, 359, 1872, 10.1016/S0140-6736(02)08783-4 · DOI
  81. Sibai, 2005, Diagnosis, prevention, and management of eclampsia, Obstetrics & Gynecology, 105, 402, 10.1097/01.AOG.0000152351.13671.99 · DOI · Paper page
  82. Slater, 1987, Phenytoin infusion in severe pre-eclampsia, Lancet, 1, 1417, 10.1016/S0140-6736(87)90603-9 · DOI
  83. Villar, 2003, Eclampsia and pre-eclampsia: a health problem for 2000 years, 189
  84. World Health Organization, 1988, Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy, American Journal of Obstetrics and Gynecology, 158, 80
  85. World Health Organization, 2006, Pregnancy, childbirth, postpartum and newborn care - A guide for essential practice
  86. Zuspan, 1978, Problems encountered in the treatment of pregnancy-induced hypertension. A point of view, American Journal of Obstetrics and Gynecology, 131, 591, 10.1016/0002-9378(78)90816-5 · DOI
  87. Duley, 2003, Magnesium sulphate versus phenytoin for eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000128 · DOI

Cited by

See all 246

Metadata

Authors
Duley, L., Henderson-Smart, D. J., & Chou, D.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2010-10-06
Volume
2010
Issue
10
Pages
CD000128-CD000128
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W1881403692
Cited by
246
References
2
FWCI
31.81
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Magnesium sulphate versus phenytoin for eclampsia. https://app.cochat.ai/papers/10.1002/14651858.cd000128.pub2
The paper
Duley, L., Henderson-Smart, D. J., & Chou, D. (2010). Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd000128.pub2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.